Literature DB >> 12727106

Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle.

Matthew L Springer1, Clare R Ozawa, Andrea Banfi, Peggy E Kraft, Tze-Kin Ip, Timothy R Brazelton, Helen M Blau.   

Abstract

We have shown previously that implantation of myoblasts constitutively expressing the VEGF-A gene into nonischemic mouse skeletal muscle leads to overgrowth of capillary-like blood vessels and hemangioma formation. These aberrant effects occurred directly at the implantation site. We show here that these regions result from angiogenic capillary growth and involve a change in capillary growth pattern and that smooth muscle-coated vessels similar to arterioles form directly adjacent to the implantation site. Myoblasts genetically engineered to produce VEGF were implanted into mouse leg muscles. Implantation sites were surrounded by a zone of dense capillary-sized vessels, around which was a second zone of muscle containing larger, smooth-muscle-covered vessels but few capillaries, and an outer zone of muscle exhibiting normal capillary density. The lack of capillaries in the middle region suggests that the preexisting capillaries adjacent to the implantation site underwent enlargement and/or fusion and recruited a smooth muscle coat. Capillaries at the implantation site were frequently wrapped around VEGF-producing muscle fibers and were continuous with the circulation and were not observed to include bone-marrow-derived endothelial cells. In contrast with the distant arteriogenesis resulting from VEGF delivery described in previous studies, we report here that highly localized arterioles also form adjacent to the site of delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727106     DOI: 10.1016/s1525-0016(03)00010-8

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  27 in total

Review 1.  Fishing for novel angiogenic therapies.

Authors:  Kameha R Kidd; Brant M Weinstein
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 2.  Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.

Authors:  Georges von Degenfeld; Andrea Banfi; Matthew L Springer; Helen M Blau
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

3.  Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

Authors:  Clare R Ozawa; Andrea Banfi; Nicole L Glazer; Gavin Thurston; Matthew L Springer; Peggy E Kraft; Donald M McDonald; Helen M Blau
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

4.  Angiomyeloproliferative lesions following autologous stem cell therapy.

Authors:  Duangpen Thirabanjasak; Kavirach Tantiwongse; Paul Scott Thorner
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

5.  Muscle satellite cells and endothelial cells: close neighbors and privileged partners.

Authors:  Christo Christov; Fabrice Chrétien; Rana Abou-Khalil; Guillaume Bassez; Grégoire Vallet; François-Jérôme Authier; Yann Bassaglia; Vasily Shinin; Shahragim Tajbakhsh; Bénédicte Chazaud; Romain K Gherardi
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

6.  Balanced single-vector co-delivery of VEGF/PDGF-BB improves functional collateralization in chronic cerebral ischemia.

Authors:  Aiki Marushima; Melina Nieminen; Irina Kremenetskaia; Roberto Gianni-Barrera; Johannes Woitzik; Georges von Degenfeld; Andrea Banfi; Peter Vajkoczy; Nils Hecht
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-09       Impact factor: 6.200

7.  Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia.

Authors:  Sudhakar Veeranki; Srikanth Givvimani; Sathnur Pushpakumar; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

8.  Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164.

Authors:  Veronica Sacchi; Rainer Mittermayr; Joachim Hartinger; Mikaël M Martino; Kristen M Lorentz; Susanne Wolbank; Anna Hofmann; Remo A Largo; Jeffrey S Marschall; Elena Groppa; Roberto Gianni-Barrera; Martin Ehrbar; Jeffrey A Hubbell; Heinz Redl; Andrea Banfi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

Review 9.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

10.  Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle.

Authors:  Bridget M Deasy; Joseph M Feduska; Thomas R Payne; Yong Li; Fabrisia Ambrosio; Johnny Huard
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.